USNA Stock Recent News

SALT LAKE CITY , Oct. 10, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. is proud to announce that the Prescribers' Digital Reference® (PDR) has recently included 11 of USANA's products to their list of trusted drugs and supplements. This recognition adds further credibility to the world-renowned quality of USANA's products while placing supplemental facts directly in the hands of prescribers.

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter 2024 results will be released after the close of market on Tuesday, October 22, 2024. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and inst.

40 Gold, 33 Silver, and 26 Bronze won SALT LAKE CITY , Sept. 19, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. would like to congratulate all 265 sponsored USANA Athletes who competed at the 2024 Summer Olympic and Paralympic Games in Paris.

SALT LAKE CITY , Aug. 19, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. has recently added two new products to its line of high-quality, science-based products. Celavive Resurfacing Serum blends powerful, clinically proven ingredients formulated to visibly transform the look of your skin.

SALT LAKE CITY , Aug. 1, 2024 /PRNewswire/ -- Inspired by Olympians, Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA), is urging all to dig deep into their inner strength to excel in their personal and professional life. "Today's elite athlete shows tremendous discipline, resilience, determination and grit, all traits that develop winners in life," Guest said.

USANA Health Sciences (USNA) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.89 per share a year ago.

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 29, 2024. Key Financial & Operating Results Second quarter net sales were $213 million versus $238 million during Q2 2023. Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023. Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million and $2.40 to $2.55 (previously $850 million to $.

Sponsored athletes to represent 10 nations across multiple disciplines in Paris SALT LAKE CITY , July 17, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. wishes the very best for the 284 sponsored USANA Athletes who earned their spot at the 2024 Summer Olympic and Paralympic Games in Paris. These athletes represent 10 nations including Canada, China, France, Indonesia, Italy, Mexico, Malaysia, South Korea, Spain, and the United States.

CEO Jim Brown visits the country to meet the local team, leaders, and share long-term vision for the market NEW DELHI , July 8, 2024 /PRNewswire/ -- Reaching one million active customers is the first step towards USANA Health Sciences, Inc.'s mission of building the healthiest family on earth—making international expansion a critical initiative. In late 2023, USANA opened its business to the India market, and for the first time since that opening, USANA's President and CEO Jim Brown will be visiting the country.

Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck right now?